Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

BACKGROUND: Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD). However, there are concerns that dexamethasone may inc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Onland, Wes, Offringa, Martin, Cools, Filip, De Jaegere, Anne P, Rademaker, Karin, Blom, Henry, Cavatorta, Eric, Debeer, Anne, Dijk, Peter H, van Heijst, Arno F, Kramer, Boris W, Kroon, Andre A, Mohns, Thilo, van Straaten, Henrica L, te Pas, Arjan B, Theyskens, Claire, van Weissenbruch, Mirjam M, van Kaam, Anton H
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245429/
https://ncbi.nlm.nih.gov/pubmed/22070744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-11-102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados